Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 25-26 June 2018
Notification for acquisition of own shares
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 26 June 2018 the Company bought 19 373 own shares representing 0.0144%
Notification from Sopharma AD under Art. 19 of Regulation (EU) No 596/2014 of 26 June 2018
Notification for received approval from the FSC of the contract for transformation through merger of Unipharm AD in Sopharma AD
Notification for acquisition of own shares
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 25 June 2018 the Company bought 28 951 own shares representing 0.021% of the share capital of the Company,
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of June, 25 2018
Notification from Sopharma AD under Art. 19 of Regulation (EU) No 596/2014 of June, 25 2018
Notification for acquisition of own shares
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 22 June 2018 the Company bought 4 740 own shares representing 0.0035% of the share capital of the Company, at a total value of 20 002.80 BGN on the Bulgarian Stock Exchange, the average price per share was 4.22 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after these transactions is 9 079 396, representing 6.74% of the share capital of the Company.